← SynDRA
ADEFOVIR DIPIVOXIL
SynDRA canonical compound SYN0002573 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Mechanism of action | DNA polymerase inhibitor |
| Indication | hepatitis B |
| Disease area | infectious disease |
All known targets
Mechanisms of action (all sources)
- DNA polymerase inhibitor
- Modulator
- P INHIBITOR
Drug classes
- Nucleoside Reverse Transcriptase Inhibitors
- Anti-Infective Agents
- Antiviral Agents
- Enzyme Inhibitors
- Nucleic Acid Synthesis Inhibitors
- Reverse Transcriptase Inhibitors
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- hepsera
- preveon
- Adefovir pivoxil
- Adefovir di(pivaloyloxymethyl) ester
- GS-0840
- Hepsera
- Adefovirdipivoxl
- Preveon
- YouHeDing
- Adefovir depivoxil
- GS 840;Piv2PMEA
- Adefovir dipivoxil (USAN)
- Adefovir pivoxil (JAN)
- Bis(pom)PMEA
- Bis-POM PMEA
- GS-840
- Hepsera (TM)
- Hepsera (TN)
- Preveon (TN)
- Bis(POM)-PMEA
- Bis-POM PMEA, Adefovir Dipivoxil
- Bis-POM PMEA, Preveon, Hepsera, Adefovir Dipivoxil
- Bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine
- [2-(6-aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate
- Propanoic acid,2,2-dimethyl-(((2-(6-amino-9H-purin-9-yl)ehtoxy)mehtyl)phosphinyldiene)bis(oxymehtylene)ester
- Propanoic acid, 2,2-dimethyl-, (((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphinylidene)bis(oxymethylene) ester
- (((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphinylidene)bis(oxymethylene) 2,2-dimethylpropanoate
- ((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid, diester with hydroxymethyl pivalate
- 9-(2-((-Bis((pivaloyloxy)methoxy)phosphinyl)methoxy)ethyl)adenine
- 9-(2-((Bis((pivaloyloxy)methoxy)phosphinyl)methoxy)ethyl)adenine
- ADV
- adefovir.dipivoxil
- bis-POM PMEA
- GS 0840
- Adefovir dipivoxil [USAN]
- Adefovir Dipivoxil (Preveon, Hepsera)
- U6Q8Z01514
Look up ADEFOVIR DIPIVOXIL in the interactive SynDRA portal →